Zydus Lifesciences informs about press release

09 Aug 2024 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated August 9, 2024 titled ‘Zydus receives final approval from USFDA for Valbenazine Capsules’. The contents of the press release give full details. Please bring the aforesaid news to the notice of the members of the exchange and the investors’ at large. The submission of press release got delayed as we had to consult our IR head and seek his advise across global time zones in India and US.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

973.90 -11.80 (-1.20%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.